VELIN-PHARMA A/S: Financial statements 2023
CVR: 33026013
Source: annual report 2023, Danish Business Authority
01/06/2022 – 31/05/2023
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 161,401 and a net result of DKK 5,547,264 compared with DKK 3,117,177 the year before. That is a decrease of 63.3% compared with the year before. Equity in the 2023 report amounted to DKK 36,788,729. The solvency ratio was 95.7%.
- Gross Profit
- DKK 161,401
- Profit/Loss
- DKK 5,547,264
- Equity
- DKK 36,788,729
- Total Assets
- DKK 38,448,470
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 161K | 5.5M | 36.8M | 0 |
| 2022 | - | 440K | 3.1M | 31.2M | 0 |
| 2021 | - | 150K | 6M | 28.1M | 0 |
| 2020 | - | 279K | 3.5M | 22.2M | - |
| 2019 | - | 139K | -998K | 18.7M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 21, 2023, Thomas Velin has joined the board of directors of VELIN-PHARMA A/S.
About VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.